Nighttime Salivary Cortisol As a Biomarker of Stress and an Indicator of Worsening Quality of Life in Patients with Head and Neck Cancer: A Cross-sectional Study

Overview

Journal Health Sci Rep

Specialty General Medicine

Date 2022 Aug 12

PMID 35957977

Authors

Marla S P Cruz

Tercio G Reis

Antoniel C Oliveira

Marluce M Macedo

Jose de Bessa

Marcio C Oliveira

Affiliations

Soon will be listed here.

Abstract

Background: Head and neck cancer (HNC) is a generic term defined on an anatomical-topographic basis to describe malignant tumors located in the oral cavity, pharynx, larynx, and thyroid. A situation commonly presented by individuals with cancer is stress, with evidence indicating a close relationship between stress, behavior, and the immune system with the development and progression of cancer.

Aim: To assess the association between stress levels and quality of life among individuals with HNC.

Methods: This was a cross-sectional study involving 72 HNC patients. The University of Washington Quality of Life Questionnaire was used to assess the quality of life, while the Perceived Stress Scale and salivary cortisol were used to evaluate stress levels.

Results: A negative association was found between quality of life and stress levels as indicated by both the PSS and nighttime salivary cortisol. Nighttime salivary cortisol showed the best accuracy estimated by the area under the receiver operating characteristic curve, slightly better than that of PSS.

Conclusion: Among the time points for saliva sampling, nighttime cortisol was found to have the best accuracy, which was similar to that of the PSS, for the detection of patients with the worst quality of life.

Citing Articles

Cancer and Stress: Understanding the Connections and Interventions.

DAndre S, Ellsworth L, Kirsch J, Montane H, Kruger M, Donovan K Am J Lifestyle Med. 2024; :15598276241304373.

PMID: 39651486 PMC: 11624519. DOI: 10.1177/15598276241304373.

Evening cortisol levels are prognostic for progression-free survival in a prospective pilot study of head and neck cancer patients.

Cash E, Beck I, Harbison B, Albert C, Sephton S Front Oncol. 2024; 14:1436996.

PMID: 39634268 PMC: 11614732. DOI: 10.3389/fonc.2024.1436996.

Circadian Rhythm Disruption in Cancer Survivors: From Oncogenesis to Quality of Life.

Kisamore C, Kisamore C, Walker 2nd W Cancer Med. 2024; 13(20):e70353.

PMID: 39463009 PMC: 11513439. DOI: 10.1002/cam4.70353.

Salivary cortisol levels in patients with potentially malignant oral disorders and oral mucosal cancer: a case-control study.

Lopez-Dalessandro E, Palomino J, Escovich L Med Oral Patol Oral Cir Bucal. 2024; 29(5):e644-e649.

PMID: 38794939 PMC: 11365055. DOI: 10.4317/medoral.26606.

Interplay between stress and cancer-A focus on inflammation.

Vignjevic Petrinovic S, Milosevic M, Markovic D, Momcilovic S Front Physiol. 2023; 14:1119095.

PMID: 37020461 PMC: 10067747. DOI: 10.3389/fphys.2023.1119095.

References

McEwen B . Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol Aging. 2002; 23(5):921-39. DOI: 10.1016/s0197-4580(02)00027-1. View

Dobrossy L . Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev. 2005; 24(1):9-17. DOI: 10.1007/s10555-005-5044-4. View

Bernabe D, Tamae A, Issamu Miyahara G, Sundefeld M, Oliveira S, Ricardo Biasoli E . Increased plasma and salivary cortisol levels in patients with oral cancer and their association with clinical stage. J Clin Pathol. 2012; 65(10):934-9. DOI: 10.1136/jclinpath-2012-200695. View

Schrepf A, Thaker P, Goodheart M, Bender D, Slavich G, Dahmoush L . Diurnal cortisol and survival in epithelial ovarian cancer. Psychoneuroendocrinology. 2015; 53:256-67. PMC: 4440672. DOI: 10.1016/j.psyneuen.2015.01.010. View

Carlson L, Speca M, Patel K, Goodey E . Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003; 65(4):571-81. DOI: 10.1097/01.psy.0000074003.35911.41. View

Chandwani K, Ryan J, Peppone L, Janelsins M, Sprod L, Devine K . Cancer-related stress and complementary and alternative medicine: a review. Evid Based Complement Alternat Med. 2012; 2012:979213. PMC: 3403456. DOI: 10.1155/2012/979213. View

Spiegel D . Mind matters in cancer survival. JAMA. 2011; 305(5):502-3. DOI: 10.1001/jama.2011.69. View

Rebholz W, Cash E, Zimmaro L, Bayley-Veloso R, Phillips K, Siwik C . Distress and quality of life in an ethnically diverse sample awaiting breast cancer surgery. J Health Psychol. 2016; 23(11):1438-1451. DOI: 10.1177/1359105316659916. View

Sharpley C, Christie D, Bitsika V, Agnew L, Andronicos N, McMillan M . Limitations in the inverse association between psychological resilience and depression in prostate cancer patients experiencing chronic physiological stress. Psychooncology. 2017; 27(1):223-228. DOI: 10.1002/pon.4496. View

10.

Fong T, Ho R . Mindfulness facets predict quality of life and sleep disturbance via physical and emotional distresses in Chinese cancer patients: A moderated mediation analysis. Psychooncology. 2020; 29(5):894-901. DOI: 10.1002/pon.5363. View

11.

Lengacher C, Reich R, Paterson C, Shelton M, Shivers S, Ramesar S . A Large Randomized Trial: Effects of Mindfulness-Based Stress Reduction (MBSR) for Breast Cancer (BC) Survivors on Salivary Cortisol and IL-6. Biol Res Nurs. 2018; 21(1):39-49. PMC: 6700883. DOI: 10.1177/1099800418789777. View

12.

Cash E, Sephton S, Chagpar A, Spiegel D, Rebholz W, Zimmaro L . Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery. Brain Behav Immun. 2015; 48:102-14. DOI: 10.1016/j.bbi.2015.02.017. View

13.

Weinrib A, Sephton S, DeGeest K, Penedo F, Bender D, Zimmerman B . Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer. 2010; 116(18):4410-9. PMC: 3118555. DOI: 10.1002/cncr.25299. View

14.

Carlson L, Speca M, Patel K, Goodey E . Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004; 29(4):448-74. DOI: 10.1016/s0306-4530(03)00054-4. View

15.

Chaby L, Cavigelli S, Hirrlinger A, Caruso M, Braithwaite V . Chronic unpredictable stress during adolescence causes long-term anxiety. Behav Brain Res. 2014; 278:492-5. DOI: 10.1016/j.bbr.2014.09.003. View

16.

Sharma P, Sandhu S, Bhandari R, Verma I, Bhullar R, Khangura R . Estimation of cortisol levels in patients with premalignant disorders and oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2018; 22(1):27-34. PMC: 5917537. DOI: 10.4103/jomfp.JOMFP_181_16. View

17.

Schrepf A, Clevenger L, Christensen D, DeGeest K, Bender D, Ahmed A . Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability. Brain Behav Immun. 2012; 30 Suppl:S126-34. PMC: 3697797. DOI: 10.1016/j.bbi.2012.07.022. View

18.

Armer J, Clevenger L, Davis L, Cuneo M, Thaker P, Goodheart M . Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer. Cancer. 2018; 124(16):3401-3408. PMC: 6108904. DOI: 10.1002/cncr.31570. View

19.

Cruz M, Reis T, Oliveira A, Macedo M, de Bessa J, Oliveira M . Nighttime salivary cortisol as a biomarker of stress and an indicator of worsening quality of life in patients with head and neck cancer: A cross-sectional study. Health Sci Rep. 2022; 5(5):e783. PMC: 9364433. DOI: 10.1002/hsr2.783. View

20.

Chang W, Lin C . Relationships of salivary cortisol and melatonin rhythms to sleep quality, emotion, and fatigue levels in patients with newly diagnosed lung cancer. Eur J Oncol Nurs. 2017; 29:79-84. DOI: 10.1016/j.ejon.2017.05.008. View